Download - Hemorrhoids SOAP
-
7/24/2019 Hemorrhoids SOAP
1/3
(Hemorrhoids) 1
Patient Profile
20 1-2
10 2558
CC: 1-2
HPI: 3
PMH:
SH:
ALL:
SOAP note
Problem: Acute Hemorrhoids
S: 1-2 3 A:
rectum [1]
2
2 (non-pharmacological therapy)
-
7/24/2019 Hemorrhoids SOAP
2/3
(Hemorrhoids) 2
[1] 2
- proctosedyl ointment (Cinchocaine hydrochloride hydrocortisone)- scheriproct-N ointment (flucotolone pivalate lidocaine)
() IESAC
Drug for hemorrhoid Daflon Venoruton300
Active ingredient 90% micronized
diosmin 10%hesperidin
0- (beta hydroyethyl)
rutosides
CissusquadrangularisKetosterones
Indication Hemorrhoid Hemorrhoid Hemorrhoid
Efficacy Daflon ,, [4]
Annoni F [5]
. Daflon 1 20 5%
[6]
Safety Stomach and
abdominal pain, mild
diarrhea, headache
Nausea, vomiting,
heartburn, epigastric
pain
Headache, flatulence, dry
mouth, diarrhea, insomnia
Adherence Initial: 3x2 pc for 4 days
then 2x2 pc for 3 days
Maintain: 1x2 pc
Initial: 300mg 1x3 pc
Maintain: 300mg 1x2 pc
Dose: 3x3 pc
Cost 155 (15 tab) 95 (10 tab) 130 (100cap)
IESAC daflon
daflon venoruton
Plan:
Goal of therapy
-
7/24/2019 Hemorrhoids SOAP
3/3
(Hemorrhoids) 3
-
- Therapeutic plan
- 3 3
- proctosedyl ointment/ scheriproct-N ointment
Monitoring
Efficacy: Safety: Headache, flatulence, dry mouth, diarrhea, insomnia
Patient education
-
- 8-10
-
- - 15-30 -
Future plan
Reference
1. . 1. 25562. Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction: a review of its use in chronic
venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63(1):71-100.
3. Annoni F, Boccasanta P et al. Treatment of acute symptoms of hemorrhoid disease with high-dose oral
O-(beta-hydroxyethyl)-rutosides. Minerva med 1986; 77(37): 1663-8
4. . . : . 2549